Pharmacological therapy of spinal cord injury during the acute phase

Spinal Cord

Volumn 38, Issue 2, 2000, Pages 71-76

  Pointillart, V ^a   Petitjean, Me ^a   Wiart, L ^a   Vital, Jm ^a   Lassie P ^a   Thicoipe M ^a   Dabadie, P ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Methylprednisolone; Nimodipine; Spinal cord injury

Indexed keywords

METHYLPREDNISOLONE; NIMODIPINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURY; TREATMENT FAILURE;

EID: 0034104861     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100962     Document Type: Article

References (31)

1. 1 Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75: 15-26.
2. 2 Guha A, Tator CH, Piper I. Effect of a calcium blocker on posttraumatic spinal cord blood flow. J Neurosurg 1987; 66: 423.
3. 3 Fehlings MG, Tator CH, Linden RD. The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 1989; 71: 403-416.
4. 4 Guha A, Tator CH, Smith CR, Piper 1. Improvement in posttraumatic spinal-cord blood flow with a combination of a calcium channel blocker and a vasopressor. J Trauma 1989; 29: 1440-1447.
5. 5 Petitjean ME, Pointillart V. Effet de l'administration continue de nimodipine à la phase aiguë d'un traumatisme médullaire chez le babouin. Ann Fr Anesth Réanim 1992; 11: 652-656.
6. 6 Ross IB, Tator C.H. Further studies of nimodipine in experimental spinal cord injury in the rat. J Neurotrauma 1992; 8: 229-238.
7. 7 Francee PC et al. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage. J Neurosurg 1993; 79: 742-751.
8. 8 Geisler FH, Dorsey FC, Coleman WP. Past and current clinical studies with GM-I ganglioside in acute spinal cord injury. Ann Emerg Med 1993; 22: 1041-1047.
9. 9 Haghighi SS, Stiens T, Oro JJ, Madsen R. Evaluation of the calcium channel antagonist nimodipine after experimental spinal cord injury. Surg Neurol 1993; 39: 403-408.
10. 10 Ross IB, Tator C.H. Spinal cord blood flow and evoked potential responses after treatment with nimodipine or methylprednisolone in spinal cord-injured rats. Neurosurgery 1993; 33: 470-477.
11. 11 Greene KA, Marciano FF, Sonntag VKH. Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord. J Spinal Disord 1996; 9: 355-365.
12. 12 Bracken MB et al. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med 1990; 322: 1405-1411.
13. 13 Bracken MB et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: One year follow-up data. J Neurosurg 1992; 76: 23-31.
14. 14 Galandiuk S, Raque G, Appel S, Polk HC. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg 1993; 218: 419-427.
15. 15 Prendergast MR et al. Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. J Trauma 1994; 37: 576-580.
16. 16 George ER et al. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surg 1995; 61: 659-664.
17. 17 Gerhart et al. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia 1995; 33: 316-321.
18. 18 Gerndt SJ et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma 1997; 42: 279-284.
19. 19 Ditunno F, Young W, Donovan WH, Greasey G. The international standards booklet for neurological and functional classification of spinal cord injury. Paraplegia 1994; 32: 70-80.
20. 20 Greenspan L, McLellan BA, Greig H. Abbreviated Injury Scale and Injury Severity Score: A scoring chart. J Trauma 1985; 25: 60-64.
21. 21 Braun SR, Levin AB, Clark KL. Role of corticosteroids in the development of pneumonia in mechanically ventilated head trauma victims. Crit Care Med 1986; 14: 198-201.
22. 22 Williams MD et al. Steroid use is associated with pneumonia in pediatric chest trauma. J Trauma 1992; 32: 520-525.
23. 23 Campagnolo D et al. Alteration of immune system function in tetraplegics: A pilot study. Am J Phys Med Rehabil 1994; 73: 387-393.
24. 24 Aubrun F et al. Enquête auprès des médecins de Samu sur l'application du protocole de methylprednisolone en traumatologie médullaire. JEUR 1996; 9: 62-67.
25. 25 Lam AM, Winn HR, Cullen BF, Sundling N. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991; 75: 545-551.
26. 26 Robertson C et al. The effect of glucose administration on carbohydrate metabolism after head injury. J Neurosurg 1991; 74: 43-50.
27. 27 Levi L et al. Anterior decompression in cervical spine trauma: Does the timing of surgery affect the outcome? Neurosurgery 1991; 29: 216-222.
28. 28 Delamarter RB, Sherman J, Carr JB. Pathophysiology of spinal cord injury. Recovery after immediate and delayed decompression. J Bone Joint Surg 1995; 77: 1042-1049.
29. 29 Bravo P et al. Outcome after vertebral fractures with neurological lesion treated either surgically or conservatively in Spain. Paraplegia 1993; 31: 358-366.
30. 30 Kiwerski JE. Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients. Paraplegia 1993; 31: 192-196.
31. 31 Petitjean ME et al. Thoracic spinal trauma and associated injuries. Should early spinal decompression be considered? J Trauma 1995; 39: 368-372.